PUMA

Akademisches Publikationsmanagement
Publikationen sammeln, verwalten und teilen.

( en | de )

 

Disambiguierung von "Rade, Michael"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
ProstaTrend-A multivariable prognostic RNA expression score for aggressive prostate cancer

, , , , , , , , , , , , , , , , , , , , , , , , , , , und . Eur. Urol., 78 (3): 452--459 (September 2020)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Keine Personen gefunden für den Autorennamen Rade, Michael
Eine Person hinzufügen mit dem Namen Rade, Michael
 

Weitere Publikationen von Autoren mit dem selben Namen

Transcriptional states of CAR-T infusion relate to neurotoxicity – lessons from high-resolution single-cell SOM expression portraying, , , , , , , and . Frontiers in Immunology, (2022)Time to evolve: predicting engineered T cell-associated toxicity with next-generation models, , , , , , , , , and 24 other author(s). Journal for ImmunoTherapy of Cancer, 10 (5): e003486 (Mai 2022)Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer, , , , , , , , , and 8 other author(s). BMC Cancer, (Juni 2023)Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody, , , , , , , , , and 13 other author(s). Nature Medicine, 31 (4): 1145--1153 (01.04.2025)Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?, , , , , , , , , and 18 other author(s). Journal for ImmunoTherapy of Cancer, 10 (5): e003487 (Mai 2022)Virtual twins for personalised CAR T-cell therapy in myeloma, , , , , , , , , and 37 other author(s). The Lancet Haematology, 12 (7): e490–e491 (Juli 2025)ProstaTrend-A multivariable prognostic RNA expression score for aggressive prostate cancer, , , , , , , , , and 18 other author(s). Eur. Urol., 78 (3): 452--459 (September 2020)Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma, , , , , , , , , and 23 other author(s). Nature Cancer, 5 (9): 1318–1333 (April 2024)A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer, , , , , , , , , and 9 other author(s). Molecular Medicine, (Februar 2024)A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation, , , , , , , , , and . Genome Biology, (Dezember 2023)